Trials / Completed
CompletedNCT01459263
Early Outcome of Mechanochemical Endovenous Ablation
Mechanochemical Endovenous Ablation of Great Saphenous Vein Incompetence Using the ClariVeinTM Device: a Prospective Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 124 (actual)
- Sponsor
- Rijnstate Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
More than 25 percent of the general population suffers from varicose veins, which has a considerable impact on quality of life. Nowadays endovenous treatment modalities for great saphenous incompetence are widely accepted. Mechanochemical endovenous ablation is a new tumescent-less technique, that combines mechanical endothelial damage using a rotating wire with the infusion of a liquid sclerosant. The current study aims at evaluating short and long term outcome after mechanochemical endovenous ablation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ClariVein | Using the ClariVein device, the GSV will be occluded. |
Timeline
- Start date
- 2010-11-01
- Primary completion
- 2018-02-01
- Completion
- 2018-02-01
- First posted
- 2011-10-25
- Last updated
- 2018-04-26
Locations
2 sites across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT01459263. Inclusion in this directory is not an endorsement.